CSP International Holdings LLC, 1175 W Bitters Rd, Ste 2203, San Antonio, TX 78216, US

Emtora Biosciences is a San Antonio-based company specializing in the commercialization of eRapa, a targeted formulation of rapamycin. Their innovative approach aims to suppress the onset and recurrence of cancer, offering potential solutions for rare genetic diseases and various early-stage cancers or precancerous conditions. With a focus on cancer prevention, Emtora Biosciences develops eRapa, a novel formulation of rapamycin that can extend life by delaying the onset of aging-related diseases and mitigating the effects of normal aging. Their leading indications include non-muscle invasive bladder cancer, low-grade prostate cancer, and Familial Adenomatous Polyposis (FAP), a rare genetic disease that leads to colon cancer, for which no current therapeutics exist.Generated from the website

Isaac Ayala & Associates

Rego Builders LLC

CMF Partnership LLC

GPS Wealth Strategies